Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
01/06/1999 | CN1203916A Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
01/05/1999 | US5856529 Adjustment of nervous system, endocrine function; reproduction, body weight and metabolism |
01/05/1999 | US5856354 Tachykinin antagonists |
01/05/1999 | US5856350 Psychological disorders |
01/05/1999 | US5856342 Combination of a β-receptor blocker and a local anaesthetic |
01/05/1999 | US5856335 Substituted aminothienopyridines, pharmaceutical composition and use |
01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
01/05/1999 | US5855907 Method of treatment of migraine |
01/05/1999 | US5855867 Radiological imaging |
01/05/1999 | CA2176012C Novel phenylalkylaminoalcohol carbamates and process for preparing the same |
01/05/1999 | CA2157117C Spirocyclic piperidine derivatives |
01/05/1999 | CA2152919C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
01/03/1999 | CA2236462A1 Murc |
01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
01/01/1999 | CA2236452A1 Gida1 |
01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
12/30/1998 | WO1998058934A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
12/30/1998 | WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
12/30/1998 | WO1998058652A1 Stable aspirin ointment preparations |
12/30/1998 | WO1998058651A1 Stable aspirin-containing preparations for external use |
12/30/1998 | WO1998058636A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
12/30/1998 | WO1998044936A3 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations |
12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
12/30/1998 | EP0887416A2 Human AFC1 |
12/30/1998 | EP0887415A2 Human RCE1 |
12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
12/30/1998 | EP0887350A1 Chromene derivatives, process for their preparation and pharmaceutical compositions containing them |
12/30/1998 | EP0887349A1 Tetrahydroimidazo (2,1-a)isoquinoline derivatives |
12/30/1998 | EP0887347A1 Process for the preparation of dry thioctic acid |
12/30/1998 | EP0887346A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists |
12/30/1998 | EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/30/1998 | EP0887078A1 Use of L or DL-threo-DOPS for preventing and treating the consequences of cerebral ischemia |
12/30/1998 | EP0886651A1 Persephin and related growth factors |
12/30/1998 | EP0886636A1 Novel piperidines derived from 1-/(piperazin-1-yl)aryl(oxy/amino)carbonyl/-4-aryl-piperidine as selective 5-ht-1d.beta. receptor antagonists |
12/30/1998 | EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
12/30/1998 | EP0652762B1 Novel anxiolytic |
12/30/1998 | EP0618889B1 Tri-substituted phenyl derivatives and processes for their preparation |
12/30/1998 | CN1203597A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
12/30/1998 | CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product |
12/30/1998 | CN1203530A Treatment of CNS effect of HIV with VX-475, alone or in combination with AZT or 3TC |
12/30/1998 | CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor |
12/30/1998 | CN1203235A New chromene compounds, process for their preparation and pharmaceutical compositions containing them |
12/30/1998 | CN1203228A Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
12/30/1998 | CN1203096A Powder and pellet for strengening Yang |
12/30/1998 | CN1041420C Process for preparing N-acyl-2,3-benzodiazepine derivatives |
12/30/1998 | CN1041418C Xanthine derivatives as adenosine A1 receptor antagonists |
12/30/1998 | CA2294464A1 Treatment of insulin resistance |
12/30/1998 | CA2294155A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
12/30/1998 | CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists |
12/30/1998 | CA2264022A1 Stable aspirin-containing preparations for external use |
12/30/1998 | CA2242261A1 5-[(heteroaryl)alkyl]-3-0x0-pyrido[1,2-a]benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders |
12/29/1998 | US5854286 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors |
12/29/1998 | US5854283 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
12/29/1998 | US5854268 Azetidine, pyrrolidine and piperidine derivatives |
12/29/1998 | US5854263 1- (1,4-benzodioxanyl)alkyl!-3-(heteroaryl) pyrrolidines and related compounds and their therapeutic utility |
12/29/1998 | US5854256 Quinuclidine derivatives |
12/29/1998 | US5854249 Opioid diarylmethylpiperazines and piperidines |
12/29/1998 | US5854247 Piperazine, piperidine and tetrahydropyridine derivatives useful as 5-HT1 recepter agonists |
12/29/1998 | US5854243 3-heteroaryl-1-pyrrolidinealkylthiols and derivatives thereof and their therapeutic utility |
12/29/1998 | US5854240 Methylene blue for the treatment or prophylaxis of encephalopathy caused by ifosfamide |
12/29/1998 | US5854239 Diazabicyclic neuokinin antagonists |
12/29/1998 | US5854232 Acyclic anc cyclic amides as neurotransmitter release enhancers |
12/29/1998 | US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors |
12/29/1998 | US5854220 Glial mitogenic factors, their preparation and use |
12/29/1998 | US5854217 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
12/29/1998 | US5854211 Compounds with growth hormone releasing properties |
12/29/1998 | US5854210 Use of cross-linked hemoglobin in treating subarachnoid hemorrhage |
12/29/1998 | US5854204 Aβ peptides that modulate β-amyloid aggregation |
12/29/1998 | US5854036 Sesquiteterpenic dervatives |
12/29/1998 | US5853747 Therapeutic and dietetic uses of a brain phospholipid-based complex |
12/29/1998 | US5853696 Substituted 2-carboxyalkyl-3(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
12/29/1998 | US5853695 Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions |
12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
12/29/1998 | CA2153050C Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
12/27/1998 | CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/24/1998 | DE19725664A1 3-Benzylpiperidine 3 Benzylpiperidine |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998057984A2 Torsin, torsin genes, and methods of use |
12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | WO1998057972A1 Quaternary ammonium compounds as tachykinin antagonists |
12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | WO1998057953A1 3-benzylpiperidine |
12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/23/1998 | WO1998057919A1 Selective thyroid hormone analogs |
12/23/1998 | WO1998057663A1 Neural transplantation for treating neurological disease |
12/23/1998 | WO1998057643A1 Use of draflazine-analogues for treating pain |
12/23/1998 | WO1998057637A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |